Indication and Usage: LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. The PI-experienced–patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent. Once-daily administration of LEXIVA plus ritonavir is not recommended for PI-experienced patients or any pediatric patients. LEXIVA does not cure HIV or prevent passing HIV to others.
Important Safety Information: You should not take LEXIVA if you have had an allergic reaction to LEXIVA or AGENERASE® (amprenavir). Tell your healthcare provider if you have liver or kidney problems, have diabetes or hemophilia, are allergic to sulfa medicines, or are pregnant, planning to become pregnant, or breastfeeding. CONTINUED BELOW
If you ever think you're alone, just check out an AIDS Walk—and see 40,000 people sharing the same journey.
Here are upcoming national events. Click the event to get the details and map it. Be sure to check back for HIV community updates.

*Individual experiences may vary. By prescription only.
Talk to your doctor to see if LEXIVA is right for you.
Please see the full Prescribing Information for LEXIVA
LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection.
LEXIVA does not cure HIV or prevent passing HIV to others.